rhIL-2 Recombinant Human Interleukin-2 (100 µg)

Used for studies aimed at the mechanism of IL-2/T-cell interaction, regulation of T-cell growth cycle progression, receptor characterization, and for in vitro laboratory studies of T-cell malignancies such as Adult T-cell Leukemia (ATL).

Recombinant Human Interleukin-2 (rhIL-2), previously referred to as T-Cell Growth Factor, is an important biological protein that mediates the process of clonal expansion and maintenance of T-cell proliferation. The rhIL-2 originates from the IL-2 gene found in human Jurkat cell line which was cloned into E. coli. This product differs from native IL-2 in two ways—it is not glycosylated and the protein differs at two amino acid positions (the first three N-terminal amino acids are absent, and CYS at position 125 is substituted by SER). 

What's included: 100 µg vial of rhIL-2 Recombinant Human Interleukin-2 (rhIL-2). Supplier Certificate of Analysis (CoA) is included with product shipment.

• 100 µg vial
• A recombinant protein of high specific activity and purity
• Molecular weight of 15.4 kDa
• Formulated in 2% fetal bovine serum (heat inactivated) as a stabilizer and sterile filtered
• Store at -10°C or below

• ENGLISH (PI)
• ENGLISH (SDS)

These products are supplied for research purposes only. It is not intended for use in the diagnosis or prognosis of disease, or for screening and may not be used as a confirmatory test in diagnostic situations. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.